Mirvaso 5 mg/g

Mirvaso 5 mg/g is a topical gel containing brimonidine tartrate, used for managing facial redness. This prescription medication is designed for external application and is manufactured by Galderma Laboratories, L.P.

Mirvaso 5 mg/g gel is primarily used to reduce facial redness associated with rosacea. It works by constricting blood vessels in the skin, which can help alleviate visible redness. This topical treatment is applied directly to the affected areas of the face.

Common effects of Mirvaso 5 mg/g gel may include temporary skin reactions such as burning, itching, or dryness at the application site. Some users may also experience flushing or a sensation of warmth. These effects are generally mild and temporary.

Mirvaso 5 mg/g gel should be used as directed by a healthcare professional. Avoid contact with eyes, mouth, and other mucous membranes. It is important to follow the prescribed application instructions and to avoid using the gel on broken or irritated skin.

Mirvaso 5 mg/g gel may interact with other topical medications or skincare products. It is advisable to consult a healthcare provider before using this gel alongside other treatments. Additionally, avoid using alcohol-based products on the same area as Mirvaso.